These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 542586)

  • 1. Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol.
    Jeffcoate WJ; Silverstone JT; Edwards CR; Besser GM
    Q J Med; 1979 Jul; 48(191):465-72. PubMed ID: 542586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personality characteristics and quality of life in patients treated for Cushing's syndrome.
    Sonino N; Bonnini S; Fallo F; Boscaro M; Fava GA
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):314-8. PubMed ID: 16487442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels.
    Starkman MN; Schteingart DE
    Arch Intern Med; 1981 Feb; 141(2):215-9. PubMed ID: 6257194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cushing's syndrome: a psychiatric study of 29 patients.
    Cohen SI
    Br J Psychiatry; 1980 Feb; 136():120-4. PubMed ID: 7370477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric phenomenology in Cushing's disease.
    Loosen PT; Chambliss B; DeBold CR; Shelton R; Orth DN
    Pharmacopsychiatry; 1992 Jul; 25(4):192-8. PubMed ID: 1528959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
    Friedman TC
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of psychiatric and psychological aspects of Cushing's syndrome.
    Kelly WF; Kelly MJ; Faragher B
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):715-20. PubMed ID: 9039337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clotting changes in Cushing's syndrome: elevated factor VIII activity.
    Dal Bo Zanon R; Fornasiero L; Boscaro M; Ruffato G; Luzzato G; Fabris F; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):268-77. PubMed ID: 6194060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup.
    Friedman TC; Zuckerbraun E; Lee ML; Kabil MS; Shahinian H
    Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease.
    Sonino N; Fava GA; Belluardo P; Girelli ME; Boscaro M
    Horm Res; 1993; 39(5-6):202-6. PubMed ID: 8314204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels.
    Starkman MN; Schteingart DE; Schork MA
    Psychosom Med; 1981 Feb; 43(1):3-18. PubMed ID: 6259680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of plasma glucagon response to arginine after treatment in patients with diabetes mellitus, cushing's syndrome and hypothyroidism.
    Seino Y; Goto Y; Kurahachi H; Sakurai H; Ikeda M
    Horm Metab Res; 1977 Jan; 9(1):28-32. PubMed ID: 844789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric disorders in Cushing's syndrome.
    Pereira AM; Tiemensma J; Romijn JA
    Neuroendocrinology; 2010; 92 Suppl 1():65-70. PubMed ID: 20829621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cushing's syndrome, tryptophan and depression.
    Kelly WF; Checkley SA; Bender DA
    Br J Psychiatry; 1980 Feb; 136():125-32. PubMed ID: 7370478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic categorization of psychiatric disturbance in Cushing's syndrome.
    Haskett RF
    Am J Psychiatry; 1985 Aug; 142(8):911-6. PubMed ID: 2992298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric disorders associated with Cushing's syndrome.
    Bratek A; Koźmin-Burzyńska A; Górniak E; Krysta K
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S339-43. PubMed ID: 26417792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric aspects of Cushing's syndrome.
    Kelly WF
    QJM; 1996 Jul; 89(7):543-51. PubMed ID: 8759496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.